Clinical Trials Logo

Clinical Trial Summary

The objective of this Phase II study is to show that pre-treated patients with BEB with the need of shortened injection intervals achieve an improved and stable quality of life level if they receive repeated NT 201 injections at short injection intervals. In addition, the tolerability of repeated shortened NT 201 administrations in patients with BEB including the development of neutralizing antibodies will be investigated.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00507637
Study type Interventional
Source Merz Pharmaceuticals GmbH
Contact
Status Terminated
Phase Phase 2
Start date August 2007
Completion date February 2008

See also
  Status Clinical Trial Phase
Completed NCT01686061 - Blepharospasm Patient Survey for Patients With Blepharospasm
Completed NCT00535938 - MDs on Botox Utility (MOBILITY) N/A
Recruiting NCT05027997 - Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm Phase 2
Terminated NCT03263000 - Photic Blink Reflex in People With Blepharospasm and Increased Blinking
Completed NCT03938363 - Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia N/A
Completed NCT02947815 - Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm Phase 2/Phase 3
Completed NCT00406367 - IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm Phase 3
Completed NCT00682760 - Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm Phase 3
Completed NCT00210431 - Post Marketing Surveillance Study of Dysport
Completed NCT05103202 - Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Completed NCT04423341 - Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm Phase 2/Phase 3
Completed NCT03269123 - A Mechanical Device for Blepharospasm N/A
Completed NCT00411255 - Brain Stimulation to Treat Blepharospasm or Meige Syndrome Phase 2
Completed NCT00500799 - Brain Changes in Blepharospasm N/A
Completed NCT00761592 - Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm Phase 4
Completed NCT00001784 - Mexiletine for the Treatment of Focal Dystonia Phase 2
Recruiting NCT04939909 - Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With Blepharospasm Early Phase 1
Completed NCT03508882 - Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm Phase 4
Completed NCT01814774 - A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm N/A
Completed NCT00234507 - Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm Phase 2